PROCEPT BIOROBOTICS CORPORATION - COMMON STOCK

PROCEPT BioRobotics' Aquablation Therapy Spotlighted at 2025 AUA Annual Meeting Along with Expert-Led Workshops

24 Apr 2025 16:03:00 By Nasdaq GlobeNewswire

PROCEPT BioRobotics Reports First Quarter 2025 Financial Results and Increases 2025 Revenue Guidance

24 Apr 2025 07:00:00 By Nasdaq GlobeNewswire

PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting at the Aria Resort in Las Vegas

10 Apr 2025 16:03:00 By Nasdaq GlobeNewswire

WATER III Randomized-Controlled Trial Results Announced at European Association of Urology Comparing Aquablation® Therapy to Laser Enucleation

24 Mar 2025 08:00:00 By Nasdaq GlobeNewswire

PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting in Las Vegas, Nevada

14 Mar 2025 08:00:00 By Nasdaq GlobeNewswire

PROCEPT BioRobotics® Reports Fourth Quarter and Full Year 2024 Results

25 Feb 2025 16:02:00 By Nasdaq GlobeNewswire

PROCEPT BioRobotics® to Report Fourth Quarter 2024 Financial Results on February 25, 2025 and Attend the TD Cowen 45th Annual Healthcare Conference and the 2025 Leerink Partners Healthcare Conference

07 Feb 2025 08:00:00 By Nasdaq GlobeNewswire

PROCEPT BioRobotics to Present at Upcoming 36th Annual Piper Sandler Healthcare Conference on December 4, 2024

26 Nov 2024 16:05:00 By Nasdaq GlobeNewswire

PROCEPT BioRobotics Corporation Announces Pricing of Offering of Common Stock

29 Oct 2024 20:43:29 By Nasdaq GlobeNewswire

PROCEPT BioRobotics Corporation Announces Proposed Offering of Common Stock

28 Oct 2024 16:19:20 By Nasdaq GlobeNewswire

PROCEPT BioRobotics® Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance

28 Oct 2024 07:00:00 By Nasdaq GlobeNewswire

PROCEPT BioRobotics to Report Third Quarter 2024 Financial Results on October 28, 2024

09 Oct 2024 16:04:00 By Nasdaq GlobeNewswire

PROCEPT BioRobotics Received U.S. FDA Approval to Initiate Pivotal Randomized Clinical Study for Prostate Cancer

07 Oct 2024 16:04:00 By Nasdaq GlobeNewswire

PROCEPT BioRobotics to Present at Upcoming 2024 Wells Fargo Healthcare Conference on September 4, 2024

28 Aug 2024 16:03:00 By Nasdaq GlobeNewswire

PROCEPT BioRobotics Announces FDA Clearance of the HYDROS™ Robotic System, the Next-Generation, AI-Powered Platform for Aquablation® Therapy

21 Aug 2024 07:00:00 By Nasdaq GlobeNewswire

PROCEPT BioRobotics® Reports Second Quarter 2024 Financial Results and Increases 2024 Revenue and EBITDA Guidance

01 Aug 2024 16:03:00 By Nasdaq GlobeNewswire

PROCEPT BioRobotics to Report Second Quarter 2024 Financial Results on August 1, 2024

15 Jul 2024 16:03:00 By Nasdaq GlobeNewswire

PROCEPT BioRobotics Announces New CPT® Category I Code from the American Medical Association for Aquablation therapy

17 Jun 2024 16:03:00 By Nasdaq GlobeNewswire

PROCEPT BioRobotics to Present at Upcoming 2024 Truist Securities MedTech Conference on June 18, 2024

03 Jun 2024 16:03:00 By Nasdaq GlobeNewswire

PROCEPT BioRobotics to Present at Upcoming 2024 Leerink Partners Healthcare Crossroads Conference and 44th Annual William Blair Growth Stock Conference

13 May 2024 16:05:00 By Nasdaq GlobeNewswire